Jun 22, 2020
Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
Jun 17, 2020
TalenTeam Awarded 'SAP Recognized Expertise' Partner Status
Jun 16, 2020
iXerv Announces Strategic Partnership Alliance with SpinifexIT
Jun 09, 2020
Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020
May 21, 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
May 12, 2020
Curis Reports First Quarter 2020 Financial Results
May 11, 2020
Rizing and SpinifexIT Announce Partnership to Streamline the Move to SAP Successfactors Employee Central Payroll
May 11, 2020
Sutro Biopharma Announces Proposed Public Offering
May 11, 2020
Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments
May 11, 2020
Sutro Biopharma Announces Pricing of $85.3 Million Public Offering
May 07, 2020
AspireHR Strengthens Leadership Team with Three Innovative Executives
Apr 21, 2020
iXerv Achieves SAP Gold Partner Status
Apr 13, 2020
Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020
Apr 07, 2020
Curis to Present at 19th Annual Needham Virtual Healthcare Conference
Mar 18, 2020
GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma
Mar 16, 2020
Sutro Biopharma Reports Full Year 2019 Financial Results and Recent Business Highlights and Developments
Mar 16, 2020
Leap Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Mar 13, 2020
iXerv appoints Patricio Alvarez Iturbe to Lead Business Development Growth in Mexico
Feb 27, 2020
Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
Feb 27, 2020
Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference